Delilah Alvarado
ReporterDelilah is a reporter for BioPharma Dive. Before Industry Dive she covered business tech and startup news and has reported on social issues, politics and culture. She has a B.S. from Texas State University and is obsessed with dogs and horror films. She can also be reached on Signal at @DelilahAlvarado.70.
518 articles by Delilah Alvarado
-
Moderna sees revenue bump from international COVID vaccine sales
May 1, 2026 -
UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy
April 30, 2026 -
Coultreon banks $125M to support testing of former Galapagos immune drug
April 28, 2026 -
Oruka surges as long-acting psoriasis drug shows early promise
April 27, 2026 -
Sanofi MS drug rejected in US gets an endorsement in Europe
April 24, 2026 -
Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director
April 16, 2026 -
Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers
April 15, 2026 -
Travere wins long-awaited approval for kidney disease drug
April 14, 2026 -
Spyre drug for inflammatory bowel disease shows promise in early study
April 13, 2026 -
Invivyd reveals plans to test an antibody drug against measles
April 9, 2026 -
Sidewinder secures $137M to advance ‘precision’ ADCs
April 8, 2026 -
Under-the-skin Tepezza comparable to infused version in key study, Amgen says
April 6, 2026 -
Pfizer, BioNTech to pause COVID vaccine study due to low enrollment
April 1, 2026 -
A ‘hijacked plane’: CDC, under RFK Jr.’s influence, trades science for dogma
April 1, 2026 -
Viridian tumbles on positive data for key eye drug prospect
March 31, 2026 -
Sanofi eczema drug weighed down by mixed results, safety concerns
March 30, 2026 -
Maze tumbles despite positive data for kidney disease drug
March 25, 2026 -
Immutrin raises $87M to advance drug for progressive heart disease
March 24, 2026 -
Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
March 23, 2026 -
Federal court blocks RFK Jr.’s moves to upend US vaccine policy
March 17, 2026 -
CytomX surges on positive data for ‘masked’ ADC in colorectal cancer
March 16, 2026 -
GSK’s RSV vaccine wins broader FDA clearance
March 13, 2026 -
Bimzelx tops Skyrizi in head-to-head psoriatic arthritis trial
March 11, 2026 -
BioNTech founders to step down and helm new mRNA startup
March 10, 2026 -
Ipsen to withdraw cancer drug acquired in buyout due to safety concerns
March 9, 2026
